Carol L. Beck

Carol L. Beck, PhD, serves as Associate Professor in the Department of Pharmacology, Physiology, & Cancer Biology within Thomas Jefferson University's College of Life Sciences, while concurrently holding leadership roles as Director of the Pharmacology MS Program and Associate Dean of the Graduate School for Biomedical Sciences. Her academic responsibilities span teaching, research mentorship, and graduate program administration across biomedical disciplines.

Dr. Beck's research program investigates ion channel physiology with dual emphases: (1) skeletal muscle channelopathies like myotonia congenita caused by CLCN-1 mutations, where diminished chloride conductance leads to sarcolemmal hyperexcitability; and (2) functional characterization of calcium-activated chloride channels (CLCA family), particularly mCLCA5 and mCLCA6 in ocular and intestinal tissues. Her laboratory employs immunohistochemistry, in situ hybridization, and electrophysiological approaches to elucidate structure-function relationships in normal physiology and disease states.

Recent publications demonstrate consistent focus on molecular mechanisms of chloride channels across multiple organ systems, with particular attention to tissue-specific expression patterns and pathological implications for channelopathies. This work bridges fundamental biophysics with translational applications in neuromuscular and ocular disorders.

As Director of the Pharmacology MS Program, Dr. Beck oversees curriculum development, student recruitment, and research training for graduate students. Her Associate Dean role involves broader strategic initiatives for the Graduate School of Biomedical Sciences, including program accreditation and interdisciplinary collaboration.

Her research team operates at the intersection of pharmacology and molecular physiology, utilizing transgenic models (including myotonic goat studies) to investigate disease mechanisms while exploring therapeutic implications of ion channel modulation.